Article PDF
Reference
Kurtzman N. Chronic renal failure: metabolic and clinical consequences. Hospital Practice 1982 (August): 107–22.
Lazurus M. Dialytic therapy: principles and clinical guidelines. Hospital Practice 1982 (October): 111–33.
Brenner B, Lazurus M. Chronic renal failure: pathophysiological and clinical considerations. Harrison’s Principles of Internal Medicine, 10th Edition, p. 1612–27.
Grodstein, G, Harrison A, Roberts Cet al. Impaired gastric emptying in haemodialysis patients (abstr). Annual Meeting Am Soc Nephrol 1979; p. 182 A.
Kuruvila C, Schrier R. Chronic renal failure. International Anesthesiology Clinics 1984; 22(1):101–17.
Opeh G, Terasaki PI. Dominant effects of transfusions on kidney graft survival. Transplantation 1980; 29:153–8.
Morris PJ. Blood transfusions and transplantation Transplantation 1978; 26:276.
Van Rood J. Blood transfusion and transplantation. Transplantation 1978; 26:275.
Tasker PRW, MacGregor GA, DeWardener HE. Prophylactic use of intravenous saline in patients with chronic renal failure undergoing major surgery. Lancet 1974; 2:911.
Rabiner SF, Drake RF. Platelet function as an indicator of adequate dialysis. Kidney Int 1975; 7:S 144.
Stewart JH, Castaldi PA. Uraemic bleeding: a reversible platelet defect corrected by dialysis. QJ Med 1967; 143:409.
Hampers CL, Blaufox MD, Merrill JP. Anti- coagulation rebound after haemodialysis. N Eng J Med 1966; 275:776.
Bastron RD, Deutsch S. Anaesthesia for the functionally anephric patient. Anaesthesia and the Kidney - The Scientific Basis of Clinical Anaesthesia, New York: Gmne & Stratton, 1976; p. 65.
Ghonheim MM,Long JP. The interaction between magnesium and other neuromuscular blocking agents. Anesthesiology 1970; 32:23.
Kraynach BJ. Calcium channel blocking agents: side effects and drug interaction. Annual Refresher Course Lectures, Chap. 238, 1983; American Society of Anesthesiologists.
Reves JG, Kissin I, Lell WAet al. Calcium entry blockers: uses and implications for anaesthesio-logists. Anesthesiology 1982; 57:504–18.
Breimer DD, Jochemsen R, Von Albert HH. Phar-macokinetics of benzodiazepenes. Drug Research 1980; 30:875–81.
Husemeyer RPet al. Cimetidine as a single oral dose for prophylaxis against Mendelson’s syndrome. Anaesthesia 1978; 33, 775–8.
Manchikanti Let al. Cimetidine and related drugs in anesthesia. Anesth Analg 1982; 61:595–608.
Carlier M, Squifflet JPet al. Maximal hydration during anaesthesia increases pulmonary artery pressure and improves function of human renal transplants. Transplantation 1982; 34:201–4.
Wyant GM. The anaesthetists looks at tissue transplantation: three years’ experience with kidney transplants. Can Anaesth Soc J 1967; 14:255.
Vandam LD, Harrison JH, Murray JEet al. Anaesthesia aspects of renal homotransplantation in man. Anesthesiology 1962; 23:783.
Linke CL, Merin RG. A regional anaesthetic approach for renal transplantation. Anesth Analg 1976; 55:69–73.
Bromage PR, Gertel M. Brachial plexus anesthesia in chronic renal failure. Anesthesiology 1972; 36:488–93.
Maddern PJ. Anaesthesia for the patient with impaired renal function. Anaesth Intensive Care 1983; 11:321–8.
Englesson S, Grevsten S. The influence of acid-base changes on central venous sytem toxicity of local anaesthetics. Acta Anaesthesiol Scand 1974; 18:88–103.
Gould DB, Aldrete JA. Bupivicaine cardiotoxicity in a patient with renal failure. Act Anaesthesiol Scand 1983; 27:18–21.
Ghoneim, Pandya H. Plasma protein binding of thiopental inpatients with impaired renal or hepatic function. Anesthesiology 1975; 42:545.
Freeman RB, Sheff MFet al. The blood-cerebro-spinal fluid barrier in uraemia. Ann Int Med 1962; 56:233.
Gorman HM, Graythorne NWB. The effect of a new neuroleptic analgesic agent (Innovar) on renal function in man. Acta Anaesthesiol Scand Suppl 1966; 24(10):111.
Morgan M, Lumley J. Anaesthetic considerations in chronic renal failure. Anaesth Intensive Care 1975; 3:218.
Trudnowski RJet al. Neuroleptanalgesia for patients with kidney malfunction. Anesth Analg 1971; 50:679.
Kono K, Philbin DM, Coggins CHet al. Renal function and stress response during halothane or fentanyl anaesthesia. Anesth Analg 1981; 60:552–6.
Philbin DM, Coggins CH. Plasma and diuretic hormone levels in cardiac surgical patients during morphine and halothane anesthesia. Anesthesiology 1978; 49:95.
Don HF, Dipeea RA, Taylor P. Narcotic analgesics in anuric patients. Anesthesiology 1975; 42:745.
Drayes DE. Active drug metabolites and renal failure. Am J Med 1977; 62:486–9.
Day S. Plasma potassium changes following suxa-methonium in normal patients and in patients with renal failure. Br J Anaesth 1976; 48:1011–4.
Miller RD, Way WL, Hamilton WKet al. Succinyl-choline induced hyperkalemia in patients with renal failure. Anesthesiology 1972; 36:138–41.
Walton JD, Farman JV. Suxamethonium hyper-kalaemia in uraemic neuropathy. Anaesthesia 1973; 28:66–8.
Ryan DW. Preoperative serum cholinesterase concentration in chronic renal failure. Br J Anaesth 1977; 49:945–9.
McLeod K, Watson MJ, Rawlins MD. Pharmaco-kinetics of pancuronium in patients with normal and impaired renal function. Br J Anaesth 1976; 48:341–5.
Bowman WG. Neuromuscular blocking agents. Pharmacology of neuromuscular function. John Wright, Bristol 1980; 71–121.
Miller RD,et al. Enhancement of d-tubocurarine neuromuscular blockade by diuretics in man. Anesthesiology 1976; 45:442–5.
Cohen EN, Brewer HW, Smith D. The metabolism and elimination of d-tubocurarine -H3. Anesthesiology 1967; 28:309–17.
Meistelman C, Lienhart A, Leveque C,et al. Pharmacology of vecuronium in patients with end stage renal failure. Anesthesiology 1983; 59:293.
Hunter JM, Jones RS, Utting JE. Use of the muscle relaxant altracurium in anephric patients. Prelim Comm J Royal Society of Medicine 1982; 75:336–40.
Fahey MRet al. Pharmacokinetics of atracurium in normal and renal failure patients. Anesthesiology 1983; 59:A263.
Cousins MJ, Maize RI. Methoxyflurane nephro-toxicity. A study of dose response in man. JAMA 1973; 225:1611–6.
Cousins MJ, Creenstein LR, Hitt BA. Metabolism and renal effects of enflurane in man. Anesthesiology 1976; 44:44.
Maize RI, Stevenpiper JS. Renal effects of enflurane and halothane in patients with abnormal renal function. Anesthesiology 1984; 60:161–3.
Harriett MN, Lane W, Bennett WM. Non-oliguric renal failure and enflurane. Ann Int Med 1974; 81:560.
Lochning R, Mazze RI. Possible nephrotoxicity from enflurane in patient with severe renal disease. Anesthesiology, 1974, 40:203–5.
Eichorn JH, Hedley-Whyte Jet al. Renal failure following enflurane anesthesia. Anesthesiology, 1976; 45:557–60.
Mazze RI, Cousins MJ, Barr GA. Renal effects and metabolism of isoflurane in man. Anesthesiology, 1974; 40:536–42.
Berry AJ. Respiratory support and renal function. Anesthesiology 1981; 55:655–67.
Stanski DR, Miller RD, Sheiner LB. Renal function and the pharmacokinetics of neostigmine in anesthetized man. Anesthesiology 1979; 51:222–6.
Cronnelly R, Stanski DR, Miller RD, Sheiner LB. Pyridostigmine kinetics with and without renal function. Clin Pharmacol Ther 1980; 28:78–81.
Miller RD,Cullen DJ. Renal failure and postoperative failure: recurarization Br J Anaesth 1976; 48:253–6.
Miller RD. Reversal of neuromuscular blockade. 1978 Annual Refresher Course Lectures. Lecture 216. American Society of Anesthesiologists.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weir, P.H.C., Chung, F.F. Anaesthesia for patients with chronic renal disease. Can Anaesth Soc J 31, 468–480 (1984). https://doi.org/10.1007/BF03015428
Issue Date:
DOI: https://doi.org/10.1007/BF03015428